Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver

Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kineti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicologic pathology 1997-03, Vol.25 (2), p.165-176
Hauptverfasser: Lalwani, Narendra D., Dethloff, Lloyd A., Haskins, Jeffrey R., Robertson, Donald G., De La Iglesia, Felix A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 176
container_issue 2
container_start_page 165
container_title Toxicologic pathology
container_volume 25
creator Lalwani, Narendra D.
Dethloff, Lloyd A.
Haskins, Jeffrey R.
Robertson, Donald G.
De La Iglesia, Felix A.
description Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kinetics and the dynamics of rat liver DNA synthesis after treatment with a peroxisome proliferator. Immunofluorescent detection of proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) incorporation into DNA during S phase were used to assess rat hepatocyte proliferation in vivo during dietary administration of Wy-14,643, a known peroxisome proliferator and hepatocarcinogen in rodents. Rats were placed on a diet containing 0.1% Wy-14,643 and implanted subcutaneously with 5-bromo-2'-deoxyuridine containing osmotic pumps 4 days prior to being sacrificed on days 4, 11, and 25 of treatment. Isolated liver nuclei labeled with fluorscein isothiocyanate (FITC)-anti-BrdU/PI and FITC-anti-PCNA/PI were analyzed for S-phase kinetics using flow cytometry. Morphometric analysis was performed to evaluate nuclear and cell size and enumeration of BrdU labeled cells, binucleated hepatocytes, and mitotic index. The BrdU labeling index increased 2-fold in livers of Wy-14,643-treated rats at day 4, but distribution of cells in G1, S phase, and G 2-M did not differ significantly from controls. PCNA-positive cells decreased from 36% on day 4 to 17% on day 25, whereas the percentage of PCNA-positive cells in controls increased 2-fold from day 4 to day 11 and remained unchanged up to day 25. The differences in the number of PCNA-positive nuclei between control and Wy-14,643-treated groups were statistically significant only on day 4. Binucleated hepatocytes, determined by morphometric analysis, increased slightly on day 25 in treated rats parallel to an increase in the percentage of cells in G2-M phase. Significant shifts were noted in nuclear diameter and nuclear area after 11 and 25 days of treatment with Wy-14,643. Hepatic cell populations with nuclei >9 μm diameter and nuclear area >64 μm2 increased in Wy-14,643-fed rats during the treatment period compared with the control, indicating hepatic karyomegaly and hyperploidy, whereas percentage of distribution of nuclei based on diameter and area remained consistently unchanged in control animals from 4 through 25 days of sham treatment. The flow cytometric and morphometric analysis indicated an initial wave of DNA synthesi
doi_str_mv 10.1177/019262339702500206
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755137164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_019262339702500206</sage_id><sourcerecordid>755137164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-bfb60f72eb721e6e15c72d0bac865d71a7e4579721853d6219b5e1172f26af673</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOj7-gCBkIbixmps0yXQpg4-BQQcf65KmtxrpNJq0ov_eDDOIILjK4nznXPIRcgjsDEDrcwYFV1yIQjMuGeNMbZARSCEyUAw2yWgJZEtih-zG-MoYjCFn22S7AC61liPip50NaCLW9HawLZpA56139dcpvfU9nWDb0nnwrWswmN757pROI30YYm9cl0quo_0L0jkG_-miX-Av2ofsMW33Cbs3PZ25Dwz7ZKsxbcSD9btHnq4uHyc32ezuejq5mGU2z0WfVU2lWKM5VpoDKgRpNa9ZZexYyVqD0ZhLXaRwLEWtOBSVxOSEN1yZRmmxR05Wu2_Bvw8Y-3Lhok2_MR36IZZaShAaVJ5IviJt8DEGbMq34BYmfJXAyqXm8q_mVDpazw_VAuufytpryo_XuYnWtE0wnXXxB-NKjIGxhJ2vsGiesXz1Q-iSlP8OfwP8bZE9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755137164</pqid></control><display><type>article</type><title>Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver</title><source>MEDLINE</source><source>SAGE Journals</source><source>Alma/SFX Local Collection</source><creator>Lalwani, Narendra D. ; Dethloff, Lloyd A. ; Haskins, Jeffrey R. ; Robertson, Donald G. ; De La Iglesia, Felix A.</creator><creatorcontrib>Lalwani, Narendra D. ; Dethloff, Lloyd A. ; Haskins, Jeffrey R. ; Robertson, Donald G. ; De La Iglesia, Felix A.</creatorcontrib><description>Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kinetics and the dynamics of rat liver DNA synthesis after treatment with a peroxisome proliferator. Immunofluorescent detection of proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) incorporation into DNA during S phase were used to assess rat hepatocyte proliferation in vivo during dietary administration of Wy-14,643, a known peroxisome proliferator and hepatocarcinogen in rodents. Rats were placed on a diet containing 0.1% Wy-14,643 and implanted subcutaneously with 5-bromo-2'-deoxyuridine containing osmotic pumps 4 days prior to being sacrificed on days 4, 11, and 25 of treatment. Isolated liver nuclei labeled with fluorscein isothiocyanate (FITC)-anti-BrdU/PI and FITC-anti-PCNA/PI were analyzed for S-phase kinetics using flow cytometry. Morphometric analysis was performed to evaluate nuclear and cell size and enumeration of BrdU labeled cells, binucleated hepatocytes, and mitotic index. The BrdU labeling index increased 2-fold in livers of Wy-14,643-treated rats at day 4, but distribution of cells in G1, S phase, and G 2-M did not differ significantly from controls. PCNA-positive cells decreased from 36% on day 4 to 17% on day 25, whereas the percentage of PCNA-positive cells in controls increased 2-fold from day 4 to day 11 and remained unchanged up to day 25. The differences in the number of PCNA-positive nuclei between control and Wy-14,643-treated groups were statistically significant only on day 4. Binucleated hepatocytes, determined by morphometric analysis, increased slightly on day 25 in treated rats parallel to an increase in the percentage of cells in G2-M phase. Significant shifts were noted in nuclear diameter and nuclear area after 11 and 25 days of treatment with Wy-14,643. Hepatic cell populations with nuclei &gt;9 μm diameter and nuclear area &gt;64 μm2 increased in Wy-14,643-fed rats during the treatment period compared with the control, indicating hepatic karyomegaly and hyperploidy, whereas percentage of distribution of nuclei based on diameter and area remained consistently unchanged in control animals from 4 through 25 days of sham treatment. The flow cytometric and morphometric analysis indicated an initial wave of DNA synthesis in response to Wy-14,643. The hepatomegaly was sustained over the treatment period accompanied by increase in ploidy with a significant shift toward hyperploidic hepatocytes. The increase in DNA content was almost entirely accounted for by the overall polyploidy increase rather than by an absolute increase in cells.</description><identifier>ISSN: 0192-6233</identifier><identifier>EISSN: 1533-1601</identifier><identifier>DOI: 10.1177/019262339702500206</identifier><identifier>PMID: 9125775</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Animals ; Biological and medical sciences ; Bromodeoxyuridine - metabolism ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinogens - toxicity ; Cell Division - drug effects ; Cell Nucleus - drug effects ; Chemical agents ; Flow Cytometry ; Image Cytometry ; Liver - cytology ; Liver - drug effects ; Liver - metabolism ; Male ; Medical sciences ; Microbodies - drug effects ; Polyploidy ; Proliferating Cell Nuclear Antigen - biosynthesis ; Pyrimidines - toxicity ; Rats ; Rats, Wistar ; Retrospective Studies ; Tumors</subject><ispartof>Toxicologic pathology, 1997-03, Vol.25 (2), p.165-176</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-bfb60f72eb721e6e15c72d0bac865d71a7e4579721853d6219b5e1172f26af673</citedby><cites>FETCH-LOGICAL-c443t-bfb60f72eb721e6e15c72d0bac865d71a7e4579721853d6219b5e1172f26af673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/019262339702500206$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/019262339702500206$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>315,782,786,21828,27933,27934,43630,43631</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2638100$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9125775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lalwani, Narendra D.</creatorcontrib><creatorcontrib>Dethloff, Lloyd A.</creatorcontrib><creatorcontrib>Haskins, Jeffrey R.</creatorcontrib><creatorcontrib>Robertson, Donald G.</creatorcontrib><creatorcontrib>De La Iglesia, Felix A.</creatorcontrib><title>Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver</title><title>Toxicologic pathology</title><addtitle>Toxicol Pathol</addtitle><description>Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kinetics and the dynamics of rat liver DNA synthesis after treatment with a peroxisome proliferator. Immunofluorescent detection of proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) incorporation into DNA during S phase were used to assess rat hepatocyte proliferation in vivo during dietary administration of Wy-14,643, a known peroxisome proliferator and hepatocarcinogen in rodents. Rats were placed on a diet containing 0.1% Wy-14,643 and implanted subcutaneously with 5-bromo-2'-deoxyuridine containing osmotic pumps 4 days prior to being sacrificed on days 4, 11, and 25 of treatment. Isolated liver nuclei labeled with fluorscein isothiocyanate (FITC)-anti-BrdU/PI and FITC-anti-PCNA/PI were analyzed for S-phase kinetics using flow cytometry. Morphometric analysis was performed to evaluate nuclear and cell size and enumeration of BrdU labeled cells, binucleated hepatocytes, and mitotic index. The BrdU labeling index increased 2-fold in livers of Wy-14,643-treated rats at day 4, but distribution of cells in G1, S phase, and G 2-M did not differ significantly from controls. PCNA-positive cells decreased from 36% on day 4 to 17% on day 25, whereas the percentage of PCNA-positive cells in controls increased 2-fold from day 4 to day 11 and remained unchanged up to day 25. The differences in the number of PCNA-positive nuclei between control and Wy-14,643-treated groups were statistically significant only on day 4. Binucleated hepatocytes, determined by morphometric analysis, increased slightly on day 25 in treated rats parallel to an increase in the percentage of cells in G2-M phase. Significant shifts were noted in nuclear diameter and nuclear area after 11 and 25 days of treatment with Wy-14,643. Hepatic cell populations with nuclei &gt;9 μm diameter and nuclear area &gt;64 μm2 increased in Wy-14,643-fed rats during the treatment period compared with the control, indicating hepatic karyomegaly and hyperploidy, whereas percentage of distribution of nuclei based on diameter and area remained consistently unchanged in control animals from 4 through 25 days of sham treatment. The flow cytometric and morphometric analysis indicated an initial wave of DNA synthesis in response to Wy-14,643. The hepatomegaly was sustained over the treatment period accompanied by increase in ploidy with a significant shift toward hyperploidic hepatocytes. The increase in DNA content was almost entirely accounted for by the overall polyploidy increase rather than by an absolute increase in cells.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bromodeoxyuridine - metabolism</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinogens - toxicity</subject><subject>Cell Division - drug effects</subject><subject>Cell Nucleus - drug effects</subject><subject>Chemical agents</subject><subject>Flow Cytometry</subject><subject>Image Cytometry</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbodies - drug effects</subject><subject>Polyploidy</subject><subject>Proliferating Cell Nuclear Antigen - biosynthesis</subject><subject>Pyrimidines - toxicity</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><issn>0192-6233</issn><issn>1533-1601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMoOj7-gCBkIbixmps0yXQpg4-BQQcf65KmtxrpNJq0ov_eDDOIILjK4nznXPIRcgjsDEDrcwYFV1yIQjMuGeNMbZARSCEyUAw2yWgJZEtih-zG-MoYjCFn22S7AC61liPip50NaCLW9HawLZpA56139dcpvfU9nWDb0nnwrWswmN757pROI30YYm9cl0quo_0L0jkG_-miX-Av2ofsMW33Cbs3PZ25Dwz7ZKsxbcSD9btHnq4uHyc32ezuejq5mGU2z0WfVU2lWKM5VpoDKgRpNa9ZZexYyVqD0ZhLXaRwLEWtOBSVxOSEN1yZRmmxR05Wu2_Bvw8Y-3Lhok2_MR36IZZaShAaVJ5IviJt8DEGbMq34BYmfJXAyqXm8q_mVDpazw_VAuufytpryo_XuYnWtE0wnXXxB-NKjIGxhJ2vsGiesXz1Q-iSlP8OfwP8bZE9</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>Lalwani, Narendra D.</creator><creator>Dethloff, Lloyd A.</creator><creator>Haskins, Jeffrey R.</creator><creator>Robertson, Donald G.</creator><creator>De La Iglesia, Felix A.</creator><general>SAGE Publications</general><general>Sage</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19970301</creationdate><title>Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver</title><author>Lalwani, Narendra D. ; Dethloff, Lloyd A. ; Haskins, Jeffrey R. ; Robertson, Donald G. ; De La Iglesia, Felix A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-bfb60f72eb721e6e15c72d0bac865d71a7e4579721853d6219b5e1172f26af673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bromodeoxyuridine - metabolism</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinogens - toxicity</topic><topic>Cell Division - drug effects</topic><topic>Cell Nucleus - drug effects</topic><topic>Chemical agents</topic><topic>Flow Cytometry</topic><topic>Image Cytometry</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbodies - drug effects</topic><topic>Polyploidy</topic><topic>Proliferating Cell Nuclear Antigen - biosynthesis</topic><topic>Pyrimidines - toxicity</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lalwani, Narendra D.</creatorcontrib><creatorcontrib>Dethloff, Lloyd A.</creatorcontrib><creatorcontrib>Haskins, Jeffrey R.</creatorcontrib><creatorcontrib>Robertson, Donald G.</creatorcontrib><creatorcontrib>De La Iglesia, Felix A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicologic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lalwani, Narendra D.</au><au>Dethloff, Lloyd A.</au><au>Haskins, Jeffrey R.</au><au>Robertson, Donald G.</au><au>De La Iglesia, Felix A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver</atitle><jtitle>Toxicologic pathology</jtitle><addtitle>Toxicol Pathol</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>25</volume><issue>2</issue><spage>165</spage><epage>176</epage><pages>165-176</pages><issn>0192-6233</issn><eissn>1533-1601</eissn><abstract>Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kinetics and the dynamics of rat liver DNA synthesis after treatment with a peroxisome proliferator. Immunofluorescent detection of proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) incorporation into DNA during S phase were used to assess rat hepatocyte proliferation in vivo during dietary administration of Wy-14,643, a known peroxisome proliferator and hepatocarcinogen in rodents. Rats were placed on a diet containing 0.1% Wy-14,643 and implanted subcutaneously with 5-bromo-2'-deoxyuridine containing osmotic pumps 4 days prior to being sacrificed on days 4, 11, and 25 of treatment. Isolated liver nuclei labeled with fluorscein isothiocyanate (FITC)-anti-BrdU/PI and FITC-anti-PCNA/PI were analyzed for S-phase kinetics using flow cytometry. Morphometric analysis was performed to evaluate nuclear and cell size and enumeration of BrdU labeled cells, binucleated hepatocytes, and mitotic index. The BrdU labeling index increased 2-fold in livers of Wy-14,643-treated rats at day 4, but distribution of cells in G1, S phase, and G 2-M did not differ significantly from controls. PCNA-positive cells decreased from 36% on day 4 to 17% on day 25, whereas the percentage of PCNA-positive cells in controls increased 2-fold from day 4 to day 11 and remained unchanged up to day 25. The differences in the number of PCNA-positive nuclei between control and Wy-14,643-treated groups were statistically significant only on day 4. Binucleated hepatocytes, determined by morphometric analysis, increased slightly on day 25 in treated rats parallel to an increase in the percentage of cells in G2-M phase. Significant shifts were noted in nuclear diameter and nuclear area after 11 and 25 days of treatment with Wy-14,643. Hepatic cell populations with nuclei &gt;9 μm diameter and nuclear area &gt;64 μm2 increased in Wy-14,643-fed rats during the treatment period compared with the control, indicating hepatic karyomegaly and hyperploidy, whereas percentage of distribution of nuclei based on diameter and area remained consistently unchanged in control animals from 4 through 25 days of sham treatment. The flow cytometric and morphometric analysis indicated an initial wave of DNA synthesis in response to Wy-14,643. The hepatomegaly was sustained over the treatment period accompanied by increase in ploidy with a significant shift toward hyperploidic hepatocytes. The increase in DNA content was almost entirely accounted for by the overall polyploidy increase rather than by an absolute increase in cells.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>9125775</pmid><doi>10.1177/019262339702500206</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0192-6233
ispartof Toxicologic pathology, 1997-03, Vol.25 (2), p.165-176
issn 0192-6233
1533-1601
language eng
recordid cdi_proquest_miscellaneous_755137164
source MEDLINE; SAGE Journals; Alma/SFX Local Collection
subjects Animals
Biological and medical sciences
Bromodeoxyuridine - metabolism
Carcinogenesis, carcinogens and anticarcinogens
Carcinogens - toxicity
Cell Division - drug effects
Cell Nucleus - drug effects
Chemical agents
Flow Cytometry
Image Cytometry
Liver - cytology
Liver - drug effects
Liver - metabolism
Male
Medical sciences
Microbodies - drug effects
Polyploidy
Proliferating Cell Nuclear Antigen - biosynthesis
Pyrimidines - toxicity
Rats
Rats, Wistar
Retrospective Studies
Tumors
title Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T14%3A33%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Nuclear%20Ploidy,%20Not%20Cell%20Proliferation,%20Is%20Sustained%20in%20the%20Peroxisome%20Proliferator-Treated%20Rat%20Liver&rft.jtitle=Toxicologic%20pathology&rft.au=Lalwani,%20Narendra%20D.&rft.date=1997-03-01&rft.volume=25&rft.issue=2&rft.spage=165&rft.epage=176&rft.pages=165-176&rft.issn=0192-6233&rft.eissn=1533-1601&rft_id=info:doi/10.1177/019262339702500206&rft_dat=%3Cproquest_cross%3E755137164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=755137164&rft_id=info:pmid/9125775&rft_sage_id=10.1177_019262339702500206&rfr_iscdi=true